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Abstract
Purpose To compare functional outcomes of Wavelight Alle-
gretto Eye-Q 400Hz and Schwind Amaris 750S excimer laser
for astigmatism between 2 and 7 diopters(D).
Methods Prospective comparative non-randomized case se-
ries of 480 eyes assigned in two laser groups and further
divided into myopic and mixed astigmatism subgroups. All
treatments were centered on corneal vertex. One-year results
were compared between the groups. Statistical analysis was
performed using z-test.
Results Both Allegretto and Amaris postoperative uncorrect-
ed distance visual acuity (UDVA) improved in comparison to
preoperative corrected distance visual acuity (CDVA). The
difference was significant in the Allegretto group for myopic
astigmatism (p=0.017). There was no difference in postoper-
ative UDVA between lasers. Average sphere decreased in all
groups for both lasers (p<0.001) without difference in effec-
tiveness of spherical correction between lasers for both
groups. In Allegretto, average cylinder decreased from
−3.30D to −0.55D in myopic astigmatism (p<0.001) and
from −3.84D to −0.85D in mixed astigmatism (p<0.001). In
Amaris average cylinder decreased from −3.21D to −0.43D in
myopic astigmatism (p<0.001) and from −3.66D to −0.58D
in mixed astigmatism (p<0.001). Amaris group had less re-
sidual astigmatism (myopic astigmatism p= 0.023, mixed
astigmatism p<0.001). Mean spherical aberration shifted from
positive to negative in mixed astigmatism for both lasers.
Conclusion Both lasers are effective in terms of UDVA,
CDVA, spherical correction, and preservation of high-order
aberrations. However, Amaris was more effective in cylinder
correction.
Keywords Astigmatism . LASIK . Excimer laser . Ablation
profile . High-order aberrations
Introduction
LASER in-situ keratomileusis (LASIK) is a highly successful
keratorefractive procedure for the treatment of myopia and
low degrees of hyperopia. However, treatment of astigmatism,
especially hyperopic astigmatism, is still a therapeutic chal-
lenge, and often results in significant refractive
misscorrections [1, 2] . Recent advances in excimer laser
technology, such as the use of aspheric ablation profiles,
incorporation of higher-order aberration treatment, and eye
trackers, have presumably led to better refractive outcomes
and reduced induction of higher-order aberrations postopera-
tively [3, 4].
The Wavelight Allegretto Eye-Q is a flying-spot excimer
laser, with a pulse repetition rate of 400Hz, with two galva-
nometric scanners for positioning laser pulses. The beam is a
small-spot, <0.95 mm in diameter, with a Gaussian energy
distribution. The system has an infrared high-speed camera
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operating at 400Hz to track the patient’s eye movements that
either compensates for changes in eye position or interrupts
the treatment if the eye moves outside a preset predetermined
range. The Wavelight Allegretto Eye-Q laser delivery pro-
gram is designed to maintain a more natural corneal shape
by adjusting for the asphericity of the cornea based on the
anterior curvature readings, and minimizing the amount of
spherical aberration induced during surgery [5, 6]. The system
compensates for the slope in the cornea by delivering a rela-
tively larger number of pulses to the periphery. The Schwind
Amaris 750S is a flying-spot excimer laser with a pulse
repetition rate of 750Hz, spot diameter of 0.54 mm, and
Gaussian energy distribution. The Schwind Amaris 750S laser
delivery program also features an aspheric ablation algorithm
for refractive treatments. Depending on the planned refractive
correction, approximately 80 % of the corneal ablation is
performed with a high fluence level (>400 mJ/cm2) and this
leads to a considerable reduction in time spent treating the
cornea. Fine correction is performed for the remaining 20% of
the treatment using a low fluence level (<200 mJ/cm2), aimed
to reduce the amount ablated per pulse and smooth out the
ablated stromal bed. The laser features a five-dimensional
1050Hz infrared eye tracker with simultaneous limbus, pupil,
iris recognition, and cyclotorsion tracking integrated in the
laser delivery process. One of the optional ablation algorithms
is the “Aberration- FreeTM” package that is designed to main-
tain the preoperative levels of ocular higher-order aberrations
[7–10].
The aim of the present study was to investigate and com-
pare refractive, visual, and optical results after treatment of
high astigmatism by these two lasers.
Materials and methods
This was a prospective non randomized consecutive compar-
ative case series approved by the Ethics Committee at
“Svjetlost” Specialty Eye Hospital. The tenets of the Helsinki
agreement were followed throughout.
Between January 2010 and December 2011, 470 eyes
(274) patients with astigmatism more than 2 diopters (D) were
operated in “Svjetlost” Specialty Eye Hospital in Zagreb,
Croatia. 418 eyes (237 patients) completed one year follow
up. Only the eyes that completed 1-year follow-up were
included in this study. The eyes were divided in two groups
according to the laser platform on which were treated —
Wavelight Allegretto Eye-Q 400Hz and Schwind Amaris
750S. Within each group, the treated eyes were further
subdivided according to the type of astigmatism, myopic
astigmatism, or mixed astigmatism. A total of 188 eyes (110
patients) were included in the Allegretto group. There were
127 eyes (71 patients) with myopic astigmatism and 61 eyes
(39 patients) with mixed astigmatism. A total of 230 eyes (127
patients) were included in the Amaris group. There were 119
eyes (64 patients) with myopic astigmatism and 111 eyes (63
patients) with mixed astigmatism.
Patient allocation
Each patient was assigned to a particular laser group by
administrative staff according to the patient’s scheduling
needs and availability of technical teams required for each
laser. Although this is not a true randomization process, the
surgeon performing the treatment had no influence on patient
assignment to the groups.
Preoperative examinations
All patients underwent a complete preoperative ophthalmo-
logic examination prior to deciding if the patient met the
criteria for surgery. Patients with stable refraction, astigma-
tism ≥2.0D, regardless of the amount of myopic or hyperopic
spherical correction, were included. Ocular criteria were those
normally adopted in refractive surgery. Patients with history of
ocular surgery, abnormal corneal topography, preoperative
corneal thickness <490 μm or calculated residual stromal
bed thickness <280 μm were excluded from the study.
Examination included uncorrected distance visual acuity
(UDVA), corrected distance visual acuity (CDVA), manifest
and cycloplegic refraction, corneal topography (Pentacam
HRTM, Oculus Optikgeräte GmbH, Wetzlar, Germany),
aberrometry (L 80 wave+TM, Luneau SAS, Prunay-le-Gillon,
France), tonometry (Auto Non-Contact Tonometer, Reichert
Inc., Buffalo, NY, USA), slit-lamp and dilated funduscopic
examination. Visual acuity was measured using a standard
Snellen acuity chart at 6 m, and presented in decimal format.
The patients were asked to discontinue contact lens wear
for up to 4 weeks, depending on the type of contact lenses,
prior to the examination.
Surgical procedure and postoperative care
Prior to the surgery, two drops of topical anesthetic (Novesin,
OmniVision GmbH, Puchheim, Germany) were instilled at 2-
minute intervals, and the eye was cleaned with 2.5 %
povidone iodine. A corneal flap was cut using Moria M2
mechanical microkeratome with 90 μm head (Moria, Antony,
France). Either Wavelight Allegretto Eye-Q 400Hz (Alcon,
Forth Worth, TX, USA) or Schwind Amaris 750S (Schwind
eye-tech-solutions, Kleinostheim, Germany) were used for the
excimer laser treatment. In all patients treated with Allegretto
Eye-Q laser, the optical zone was fixed at 6.5 mm as recom-
mended by the manufacturer, and the wavefront optimized
program was used. Since the laser ablation algorithm is based
on preservation of corneal asphericity by delivering additional
laser pulses on the periphery to maintain a natural corneal
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shape, total ablation zones were wide; 8.9 mm for mixed
astigmatism and 9.0 mm for myopic astigmatism cases. For
the Amaris 750S, the mean optical zone of the treatment was
6.63±0.20 mm (range 6.5 to 7.0 mm). The rationale for
changing optical zone was based on the manufacturer’s rec-
ommendation to select, at least, a 6.7 mm optical zone for
treatment of astigmatism. However, we did not want to exceed
9.0 mm zone of total ablation. Since the transition zone
(automatically calculated by the system for the selected optical
zone and applied correction) increases with the complexity of
the applied correction, the size of an optical zone was chosen
to fit within the limits of a 9.0 mm of total ablation zone. The
total ablation zone was 8.67±0.31 mm (range 7.9 to 9.0 mm).
The Aberration FreeTM program was applied in all cases.
All ablations were centered on corneal vertex for both laser
platforms. The corneal vertex is the intersection of the pupil-
lary axis with the anterior surface of the cornea, when the
pupillary axis coincides with the optical axis of the measuring
device [11]. The position of the corneal vertex was determined
by the pupillary offset, that is the distance between the pupil
center and the normal corneal vertex [12], calculated by using
the videokeratoscope (CSO, Costruzione Strumenti Oftalmici,
Florence, Italy) for Amaris, and Scheimpflug camera
(Pentacam HRTM, Oculus Optikgeräte GmbH, Wetzlar, Ger-
many) for Allegretto. The Cartesian coordinates of the corneal
vertex were manually entered into the software program [13].
For all patients, the programmed treatment consisted of
cycloplegic spherical correction with manifest astigmatic
power and axis. For the Allegretto Eye-Q, the “Wellington
nomogram” provided by the company was used for spherical
correction. The nomogram also directs the surgeon to correct
25 % less of the full astigmatism. Our previous experience
(unpublished) showed that the 25 % modification led to
significant undercorrection. Thus, we decided to use an em-
pirically derived undercorrection of 15 % in all cases where
the Allegretto Eye-Q was used. For the Amaris 750S the
sphere, cylinder, and axis were entered into laser without
nomogram adjustment. Before excimer laser ablation, proper
alignment of the eye with Allegretto Eye-Q was achieved with
a manual cross technique to compensate for cyclotorsion.
When Amaris 750S was used for treatment, the built-in eye
tracker automatically compensated for static and dynamic
cyclotorsion of the eye. In all cases, the flap was lifted and
excimer laser ablation was delivered to the stroma. Patients
were instructed to concentrate on the fixation light throughout
the ablation. When the ablation was completed, the flap was
repositioned after the interface was irrigated with balanced salt
solution, removing any debris.
Postoperative therapy included combination of topical an-
tibiotic and steroid drops (Tobradex, Alcon, Forth Worth, TX,
USA) 4 times daily for 2 weeks, and artificial tears (Blink,
Abbott Medical Optics, Santa Ana, CA, USA) 6–8 times daily
for at least 1 month.
Postoperative evaluation
All patients were examined 1 day, 1 week, 1 month, 3 months,
and 1 year after the surgery. Results 1 year after the surgery
were analyzed in this study. Evaluation included measurement
of UDVA, CDVA, manifest refraction, aberrometry, slit-lamp
examination, tonometry, and corneal topography.
Data and statistical analysis
Data were analyzed to determine significance of change in
spherical correction, astigmatism, UDVA, CDVA, high-order
aberrations, (2-sample z-test assuming unequal variances for
data with normal distribution, and Mann–Whitney U test for
non-parametric analysis) within each group and between
groups, to determine whether there was significant difference
between two lasers. Changes and differences were considered
statistically significant when p<0.05. Spherical aberration was
further analyzedwith cluster analysis to see the trend in change.
Data were further analyzed with Pearson correlation to
determine the significance of any correlation between pre-
and postoperative sphere, cylinder, and visual acuity. Corre-
lations were considered significant when p<0.05.
Results
Both laser groups were well-balanced, and there was no
statistically significant difference preoperatively between the
groups in terms of UDVA, CDVA, sphere, cylinder, and
amount of high-order aberrations. 57 males (52 %) and 52
females (48 %) were treated on Allegretto, while 71 males
(56 %) and 56 females (44 %) were treated on Amaris.
Avarage age (years±SD) of the patients was 32.69±7.2 (range
20–58) for the Allegretto, and 33.25±6.9 (range 20–58) for
the Amaris group.
Visual acuity In the Allegretto group, values of postoperative
UDVA showed improvement in comparison to preoperative
CDVA. The difference was 0.5 Snellen lines in myopic astig-
matism, and was significant (p=0.017), while in mixed astig-
matism the difference was 0.3 Snellen lines and was not
statistically significant (p=0.406). In the Amaris group, im-
provement in postoperative UDVA in comparison to preoper-
ative CDVA was observed, but improvement of 0.5 Snellen
lines was not significant for the myopic astigmatism group (p=
0.06), neither were 0.3 Snellen lines significant for the mixed
astigmatism group (p=0.115) (Tables 1 and 2). There was no
difference in postoperative UDVA between lasers for myopic
astigmatism (p=0.967) and for mixed astigmatism Amaris was
better for 0.3 Snellen lines but without statistical significance
(p=0.151). None of the eyes lost any lines of CDVA.
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Refraction In the Allegretto group, significant decrease of
sphere and cylinder was observed for both the myopic and
mixed astigmatism groups. Average sphere decreased from
−2.80D to −0.16D in the myopic astigmatism group
(p<0.001) and from +2.72D to +0.19D in the mixed astigma-
tism group (p<0.001). Average cylinder decreased from
−3.30D to −0.55D in the myopic astigmatism group
(p<0.001), and from −3.84D to −0.85D in the mixed astig-
matism group (p<0.001) (Tables 1 and 2).
In the Amaris group, significant decrease of sphere and
cylinder was observed for both the myopic and mixed astigma-
tism groups. Average sphere decreased from −2.44D to −0.16D
in the myopic astigmatism group (p<0.001) and from +3.11D
to +0.28D in the mixed astigmatism group (p<0.001) Average
cylinder decreased from −3.21D to −0.43D in the myopic
astigmatism group (p<0.001), and from −3.66D to −0.58D in
the mixed astigmatism group (p<0.001) (Tables 1 and 2).
There was no difference in effectiveness of spherical cor-
rection between laser platforms for both myopic and mixed
astigmatism (p=0.969, p=0.236). The Amaris group had less
residual astigmatism than the Allegretto group, and the differ-
ence was significant (myopic astigmatism p=0.027, mixed
astigmatism p <0.001). The attempted and achieved astigmat-
ic corrections are shown in Figs. 1, 2, 3, and 4. In all cases,
there was a highly significant association between the
attempted and achieved astigmatic corrections. For the Alle-
gretto cases, there was a tendency toward residual cylinder in
both the myopic and mixed astigmatism groups when com-
paring the attempted cylindrical correction with the postoper-
ative cylinder (r =0.3978, p<0.01, n =127 for myopic, and r=
Table 1 Comparison of visual and refractive results at 1 year with baseline values in myopic astigmatism showing the main results of the investigation
Visual and refractive results— myopic astigmatism
Mean±standard deviation





UDVA 0.15±0.15 (0.01 to 0.70) 0.86±0.16 (0.35 to 1.00) <0.001 0.13±0.11 (0.01 to 0.45) 0.86±0.19 (0.15 to 1.00) <0.001
CDVA 0.81±0.17 (0.30 to 1.00) 0.89±0.16 (0.40 to 1.00) <0.001 0.81±0.18 (0.10 to 1.00) 0.89±0.20 (0.20 to 1.00) 0.001
sphere (D) −2.80±2.01 (−8.50 to 0.00) −0.16±0.46 (−1.50 to 1.00) <0.001 −2.44±2.17 (−7.50 to 0.00) −0.16±0.55 (−2.00 to 1.25) <0.001
cylinder (D) −3.30±1.00 (−7.50 to −2.00) −0.55±0.46 (−2.25 to 0.00) <0.001 −3.21±0.87 (−6.50 to −2.00) −0.43±0.36 (−1.50 to 0.00) <0.001
UDVA=uncorrected distance visual acuity (decimal)
CDVA=corrected distance visual acuity (decimal)
D=diopter
*2-sample z-test assuming unequal variances
Table 2 Comparison of visual and refractive results at 1 year with baseline values in mixed astigmatism showing the main results of the investigation
Visual and refractive results— mixed astigmatism
Mean±standard deviation





UDVA 0.25±0.14 (0.03 to 0.60) 0.77±0.20 (0.20 to 1.00) <0.001 0.24±0.12 (0.02 to 0.60) 0.80±0.21 (0.05 to 1.00) <0.001
CDVA 0.74±0.22 (0.15 to 1.00) 0.82±0.21 (0.20 to 1.00) 0.04 0.77±0.20 (0.04 to 0.95) 0.85±0.21 (0.10 to 1.00) 0.004
sphere (D) 2.72±1.79 (0.25 to 7.00) 0.19±0.52 (−1.50 to +1.50) <0.001 3.11±1.57 (0.50 to 7.50) 0.28±0.45 (−0.75 to 1.00) <0.001
cylinder (D) −3.84±1.21 (−6.50 to −2.00) −0.85±0.41 (−2.00 to 0.00) <0.001 −3.66±1.16 (−7.00 to −2.00) −0.58±0.38 (−1.50 to 0.00) <0.001
UDVA=uncorrected distance visual acuity (decimal)
CDVA=corrected distance visual acuity (decimal)
D=diopter
*2-sample z-test assuming unequal variances
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0.4567, p<0.01, n =61 for mixed astigmatism). Similar trends
were also found in the Amaris cases (r=0.4701, p<0.01, n
=119 for myopic, and r=0.3257, p<0.01, n =111 for mixed
astigmatism).
Aberrometry In the Allegretto group, there was no significant
change between preoperative and postoperative high-order
aberrations in the myopic astigmatism group (coma 0.592,
trefoil p=0.999, SA p =0.056). Although there was no differ-
ence in SA between preoperative and postoperative values,
SA showed a tendency to shift towards more positive values
in 54.4 % of eyes, and in 42.4 % of eyes showed a tendency to
shift towards negative values, while 3.2 % of eyes remained
unchanged. In the mixed astigmatism group, there was no
significant change in coma and trefoil (p=0.347, p =0.116)
,while spherical aberration shifted from positive to negative
values (p=0.03) (Tables 3 and 4). SA showed a tendency to
shift towards negative values in 63.3 % of eyes, and in 26.7 %
of eyes showed a tendency to shift towards more positive
values, while 10.0 % of eyes remained unchanged.
In the Amaris group, there was no significant change
between preoperative and postoperative high-order aberra-
tions in the myopic astigmatism group (coma p=0.166, trefoil
p=0.211, SA=0.504). Although there was no difference in SA
between preoperative and postoperative values, SA showed a
tendency to shift towards more positive values in 41.5 % of
eyes, and in 50.0 % showed a tendency to shift towards
negative values, while 8.5 % of eyes remained unchanged.
In the mixed astigmatism group, there was no significant
change in coma and trefoil (p=0.420, p=0.404) ,while spher-
ical aberration shifted from positive to negative values (p <
0.001) (Tables 3 and 4). SA showed a tendency to shift
towards negative values in 66.1 % of eyes, and in 29.4 % of
eyes showed a tendency to shift towards more positive values,
while 4.5 % of eyes remained unchanged.
There was no significant difference in the magnitude of
high-order aberrations between the lasers for both the myopic
astigmatism (coma p=0.137, trefoil p =0.143, SA p =0.2) and
mixed astigmatism groups (coma p=0.222, trefoil p =0.314,
SA p=1.00).
Fig. 1 Attempted vs achieved cylinder correction (D) in myopic astig-
matism with Allegretto Eye-Q. The least-squares regression line, best-fit
linear equation and R2 are included for comparison with Figs. 2, 3, & 4
Fig. 2 Attempted vs achieved cylinder correction (D) in mixed astigma-
tism with Allegretto Eye-Q. The least-squares regression line, best-fit
linear equation and R2 are included for comparison with Figs. 1, 3, & 4
Fig. 3 Attempted vs achieved cylinder correction (D) in myopic astig-
matism with Amaris 750S. The least-squares regression line, best-fit
linear equation and R2 are included for comparison with Figs. 1, 2 & 4
Fig. 4 Attempted vs achieved cylinder correction (D) in mixed astigma-
tism with Amaris 750S. The least-squares regression line, best-fit linear
equation and R2 are included for comparison with Figs. 1, 2 & 3
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Discussion
The main limitations of our study were its comparative rather
than randomized study design, and distinct differences be-
tween software and hardware of two excimer lasers in terms
of optical zone selection and eye-tracking devices.
As far as patient selection, there was no selection bias with
respect to assignment of patients to each laser group, as both
lasers were engaged in refractive surgery according to organi-
zational schedules and availability of technical teams needed
for each laser. This resulted in patient assignment to laser
group by administrative staff according to patient scheduling
needs. We understand that this is not a true randomization
process. Nevertheless, the surgeon performing the treatments
had no influence on patient assignment to the groups, and
therefore the bias was minimized.
Visual acuity There was an improvement in UDVA and no
loss in CDVA for both lasers. In one subgroup, we found post-
op UDVA was better than pre-op CDVA. Stonecipher and
Kezarian [5] found no loss of CDVA at 6 months using the
Allegretto 400Hz platform. Alió et al. [14] using the Amaris
500 platform with an aspheric profile reported 16 % of cases
lost up to 1 line on CDVA.
Refraction Correction of the sphere was very acceptable for
both lasers; however, there was a tendency towards residual
cylinder. When analyzing eyes with myopic astigmatism,
48 % of cases were within ±0.50D of intended refraction in
the Allegretto group, in comparison to 54 % in the Amaris
group (p =0.368). Our results differ from those of Stonecipher
et al. [6], who reported 94 % out of 186 cases treated with
Wavelight Allegretto 400Hz within ±0.50D of intended re-
fraction. Alió et al. [14] used the Amaris 500 platform with an
aspheric profile, and reported a predictability of 87 %. How-
ever, those data were based on 37 eyes, whereas our study was
based on 119 eyes using a different Amaris platform. The
differences between studies may result from different patient
selection criteria rather than different platforms. When ana-
lyzing eyes with mixed astigmatism, 28 % of cases were
within ±0.50D of intended refraction in the Allegretto group,
in comparison to 42% of eyes in the Amaris group (p=0.060).
Our results to some extent correlate to the study by Alió et al.
[13], which reported significant undercorrection of mixed
Table 3 Comparison of high-order aberrations (μm) on 5 mm pupil at 1 year with baseline values in myopic astigmatism, showing the main results of
the investigation
High-order aberrations— myopic astigmatism
Variable Mean±standard deviation
Wavelight Allegretto Eye-Q Schwind Amaris 750S
preop postop p value* preop postop p value*
coma (μm) 0.12±0.09 (0.01 to 0.53) 0.11±0.10 (0.01 to 0.90) 0.592 0.11±0.08 (0.00 to 0.40) 0.13±0.11 (0.01 to 0.80) 0.166
trefoil (μm) 0.11±0.06 (0.01 to 0.32) 0.11±0.13 (0.01 to 0.90) 0.999 0.10±0.06 (0.01 to 0.29) 0.09±0.08 (0.01 to 0.49) 0.211
SA (μm) −0.02±0.07 (−0.28 to 0.20) 0.00±0.05 (−0.40 to 0.22) 0.056 −0.01±0.05 (−0.23 to 0.10) −0.01±0.07 (−0.26 to 0.14) 0.504
SA=Spherical aberration (μm – micrometer)
*2-sample z-test assuming unequal variances
Table 4 Comparison of high-order aberrations (μm) on 5 mm pupil at 1 year with baseline values in mixed astigmatism, showing the main results of the
investigation
High-order aberrations— mixed astigmatism
Variable Wavelight Allegretto Eye-Q Schwind Amaris 750S
preop postop p value* preop postop p value*
coma (μm) 0.12±0.08 (0.02 to 0.45) 0.10±0.06 (0.04 to 0.28) 0.347 0.12±0.09 (0.01 to 0.46) 0.11±0.03 (0.01 to 0.53) 0.420
trefoil (μm) 0.13±0.13 (0.01 to 0.90) 0.10±0.05 (0.02 to 0.26) 0.116 0.10±0.07 (0.01 to 0.44) 0.09±0.08 (0.01 to 0.76) 0.404
SA (μm) 0.02±0.06 (−0.11 to 0.14) 0.00±0.04 (−0.09 to 0.12) 0.03 0.02±0.05 (−0.07 to 0.20) 0.00±0.04 (−0.18 to 0.10) <0.001
SA=Spherical aberration (μm – micrometer)
*2-sample z-test assuming unequal variances
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astigmatism using Amaris 500 and Aberration-Free profile.
Alió reported 26.9 % of patients being within ±0.50D of the
attempted correction, and 65.3 % being within ±1.0D.
Stonecipher et al. [5] reported the opposite outcome on Alle-
gretto 400Hz, with 100 % of patients having ≤0.50D of
residual astigmatism with r2 values >0.98.
High-order aberrations There was no significant change in
high-order aberrations in eyes with myopic astigmatism. This
finding supports the definition underlying the aspheric profiles
that were designed to keep high-order aberrations of the eyes
unchanged after photoablation. Arbelaez et al. [8] found a
statistically significant increase in high-order aberrations after
myopic astigmatism treatment on Amaris 500, which was in
correlation with the amount of refractive error treated. How-
ever, the amount of induced aberrations was lower than that
from conventional treatment [15]. Stonecipher et al. [6] did
not find a change in high-order aberration in myopic astigma-
tism up to 3.0D using wavefront optimized profile from
Allegretto Eye-Q. Our data confirm the earlier findings using
the Allegretto profile, but not the findings using the earlier
Amaris profile.
In eyes with mixed astigmatism, changes in amount of
spherical aberration have been reported with a tendency to-
wards more negative values; however, the changes were be-
low clinical significance [16–18]. We found similar, but sta-
tistically significant, trends towards negative values for both
lasers, and these support the findings of Alió et al. [13] using
the Amaris 500.
The use of a simple single spherical equivalent as an index
does not reflect the efficacy and accuracy of compound astig-
matism correction. Therefore, separate analyses of refractive
outcomes separating sphere, cylinder, and axis would be more
reasonable to evaluate surgery for astigmatism. This could
also facilitate any nomogram adjustment, with the aim of
further enhancing the accuracy of treatment.
Figures 1, 2, 3, and 4 demonstrate that there is a highly
significant association between the attempted astigmatic cor-
rection, achieved astigmatic correction, and the difference
between the attempted and achieved (ΔC). With closer scru-
tiny of our data, we noticed that residual cylinder stays in the
same direction as the original one, with a ±20° change. From
that observation, we noticed that both lasers tend to
undercorrect the astigmatism. However, in several cases with
cylindrical corrections of ≥6.0D, both lasers overcorrected,
since we observed that the postoperative axis shifted by near
90°. To scientifically support this observation, vector analysis
would be needed [19].
In summary, both lasers produced acceptable results
tending to preserve optical performances of the eye without
significant induction of high-order aberrations. There is no
difference in effectiveness between lasers for spherical correc-
tion. However, Schwind Amaris 750S demonstrated better
results and less residual cylinder than Wavelight Allegretto
Eye-Q. Nevertheless, the correction of both lasers may yield
small residual cylinder. Future studies, with more intensive
mathematical analysis of astigmatism itself, are needed to
further improve formulas and laser nomograms for cylinder
correction.
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